Primary Record
Motesanib
- In stock
- 1,438 g
- Purity
- 98.7 %
- CAS
- 453562-69-1
Compound Identifiers & Properties
- CAS
- 453562-69-1
- PubChem CID
- 11667893
- SMILES
- CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C
- Canonical SMILES
- CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21
Names & Synonyms
- Motesanib
- 453562-69-1
- motesanibum
- AMG-706
- Motesanib Base
- Motesanib?
- AMG 706
- Motesanib [USAN]
- Motesanib (USAN)
- Motesanib diphosphate
- Motesanib [USAN:INN]
- Motesanib AMG 706
- U1JK633AYI
- AMG706
- MOTESANIB [INN]
- UNII-U1JK633AYI
- Motesanib (AMG706)
- MOTESANIB [MI]
- RefChem:159829
- AMG-706(Motesanib)/
- Motesanib (AMG-706)
- D00DQX
- MOTESANIB [MART.]
- MOTESANIB [WHO-DD]
- MFCD10567689
- C22H23N5O
- CHEBI:51098
- SCHEMBL187470
- DTXSID10196488
- CHEMBL572881
- GTPL5660
- orb1305790
- QCR-80
- SCHEMBL29354461
- BDBM24773
- CTK8D4046
- 453562-69-1 (free base)
- DTXCID20118979
- EX-A487
- SYN1055
- cid_11667893
- BCPP000407
- GLXC-90205
- HMS3244A09
- HMS3244A10
- HMS3244B09
- HMS3265G19
- HMS3265G20
- HMS3265H19
- HMS3265H20
- Motesanib Diphosphate (AMG-706)
- AOB87176
- BCP01982
- KS-00000XP7
- N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethylamino)nicotinamide
- AMG 706; AMG-706
- ABP000879
- AN-560
- NSC760843
- NSC800801
- RS0100
- s5793
- ZINC18710082
- AKOS005146333
- BCP9000289
- CS-0028
- CS-1108
- DB05575
- EX-8571
- FM65094
- NSC-760843
- NSC-800801
- SB14621
- SDCCGSBI-0654329.P001
- CID11667893
- NCGC00263205-01
- NCGC00263205-06
- 4CA-0148
- AC-32664
- AK326502
- AS-16212
- BC659946
- HY-10228
- SC-28323
- N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide
- AB0007900
- TC-063059
- 2554B
- A3632
- A5017
- FT-0706483
- N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide
- NS00071589
- X4931
- J2.121.082J
- PA-11667893
- A11496
- A19395
- D06678
- W-5450
- 562M691
- N-(3,3-dimethylindolin-6-yl)-2-((pyridin-4-ylmethyl)amino)nicotinamide
- Q6917202
- BRD-K99616396-001-05-1
- BRD-K99616396-316-01-2
- BRD-K99616396-316-04-6
- BRD-K99616396-316-05-3
- BRD-K99616396-316-06-1
- N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide
- N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethyl
- B0084-069090
- N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-3-pyridinecarboxamide
- 857876-30-3
- N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4- ylmethyl)amino]pyridine-3-carboxamide
- N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)pyridine-3-carboxamide
- N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)nicotinamide
- 3-Pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-
- N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide
- N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-{[(pyridin-4-yl)methyl]amino}pyridine-3-carboxamide
- N-(3,3-Dimethylindoline-6-yl)-2-(pyridine-4-ylmethylamino)nicotinamide
- N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)-3-pyridinecarboxamide
- 113-839-3
- N-(2,3-Dihydro-3,3-dimethyl-1H-indole-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide
- N-(3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOL-6-YL)-2-((PYRIDIN-4-YLMETHYL)AMINO)NICOTINAMIDE